Enduo Qiu

472 total citations
26 papers, 342 citations indexed

About

Enduo Qiu is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Enduo Qiu has authored 26 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Enduo Qiu's work include Meningioma and schwannoma management (6 papers), MicroRNA in disease regulation (5 papers) and Head and Neck Surgical Oncology (5 papers). Enduo Qiu is often cited by papers focused on Meningioma and schwannoma management (6 papers), MicroRNA in disease regulation (5 papers) and Head and Neck Surgical Oncology (5 papers). Enduo Qiu collaborates with scholars based in China, United States and Germany. Enduo Qiu's co-authors include Wei Wang, Yi Pei, Xiaojing Zhang, Ke Zheng, Shenglong Li, Guanning Shang, Yuming Wang, Shuang Wang, Fei Liu and Wei Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Life Sciences and Molecular Cancer.

In The Last Decade

Enduo Qiu

25 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Enduo Qiu China 11 200 152 62 46 38 26 342
Hong Mu China 10 172 0.9× 122 0.8× 42 0.7× 34 0.7× 36 0.9× 32 309
Hongxia Peng China 9 223 1.1× 130 0.9× 60 1.0× 25 0.5× 22 0.6× 12 327
Jianwen Wang China 9 207 1.0× 111 0.7× 43 0.7× 29 0.6× 27 0.7× 27 328
Qishun Geng China 11 232 1.2× 108 0.7× 86 1.4× 55 1.2× 21 0.6× 28 382
Feiya Du China 12 284 1.4× 199 1.3× 80 1.3× 33 0.7× 22 0.6× 16 428
Zenong Yuan China 10 171 0.9× 69 0.5× 34 0.5× 27 0.6× 34 0.9× 21 317
Vui King Vincent–Chong Malaysia 15 243 1.2× 124 0.8× 117 1.9× 74 1.6× 46 1.2× 30 484
Lang Liu China 12 219 1.1× 159 1.0× 40 0.6× 82 1.8× 60 1.6× 33 370
Huayong Zhang China 12 238 1.2× 110 0.7× 49 0.8× 49 1.1× 35 0.9× 17 339
Cuiping Wang China 12 176 0.9× 79 0.5× 54 0.9× 30 0.7× 28 0.7× 26 312

Countries citing papers authored by Enduo Qiu

Since Specialization
Citations

This map shows the geographic impact of Enduo Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enduo Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enduo Qiu more than expected).

Fields of papers citing papers by Enduo Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enduo Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enduo Qiu. The network helps show where Enduo Qiu may publish in the future.

Co-authorship network of co-authors of Enduo Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Enduo Qiu. A scholar is included among the top collaborators of Enduo Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enduo Qiu. Enduo Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiu, Enduo & Fei Liu. (2023). PLGA-based drug delivery systems in treating bone tumors. Frontiers in Bioengineering and Biotechnology. 11. 1199343–1199343. 9 indexed citations
2.
Li, Yong, Enduo Qiu, Jian Ren, et al.. (2022). Prognosis Analysis and Clinical Features of Orbital Cavernous Venous Malformations With Refractory Insidious Onset. Frontiers in Oncology. 11. 745479–745479. 6 indexed citations
3.
Qiu, Enduo, Wei Wang, Jialiang Zhang, et al.. (2021). Factors for postoperative recurrence of orbital solitary fibrous tumor: an analysis of long‐term clinical follow‐up results from a Chinese tertiary hospital. BMC Ophthalmology. 21(1). 61–61. 10 indexed citations
4.
Jiang, Shuang, et al.. (2021). Phantom Limb Pain and Sensations in Chinese Malignant Tumor Amputees: A Retrospective Epidemiological Study. Neuropsychiatric Disease and Treatment. Volume 17. 1579–1587. 4 indexed citations
5.
Li, Shenglong, Fei Liu, Ke Zheng, et al.. (2021). CircDOCK1 promotes the tumorigenesis and cisplatin resistance of osteogenic sarcoma via the miR-339-3p/IGF1R axis. Molecular Cancer. 20(1). 161–161. 69 indexed citations
7.
Huang, Qian, Shunjiu Cui, Mingjie Wang, et al.. (2021). Outcomes and Quality-of-Life Measures after Endoscopic Endonasal Resection of Kadish Stage C Olfactory Neuroblastomas. World Neurosurgery. 151. e58–e67. 3 indexed citations
8.
Qiu, Enduo, et al.. (2020). MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway. SHILAP Revista de lepidopterología. 10 indexed citations
9.
Liu, Fei, Yi Pei, Ke Zheng, et al.. (2020). Long non-coding RNA AFAP1-AS1 accelerates the progression of melanoma by targeting miR-653-5p/RAI14 axis. BMC Cancer. 20(1). 258–258. 37 indexed citations
11.
Pei, Yi, Yueyan Zhang, Ke Zheng, et al.. (2019). <p><em>Ilex hainanensis Merr</em> targets ITGAV to suppress the proliferation and metastasis of osteosarcoma cells</p>. OncoTargets and Therapy. Volume 12. 4499–4507. 10 indexed citations
12.
Li, Shenglong, Xixi Wu, Yi Pei, et al.. (2019). PTHR1 May Be Involved in Progression of Osteosarcoma by Regulating miR-124-3p- AR-Tgfb1i1 , miR-27a-3p- PPARG-Abca1 , and miR-103/590-3p- AXIN2 Axes. DNA and Cell Biology. 38(11). 1323–1337. 12 indexed citations
13.
Li, Shenglong, Xixi Wu, Peng Chen, et al.. (2019). Interferon-α versus interleukin-2 in Chinese patients with malignant melanoma. Anti-Cancer Drugs. 30(4). 402–409. 6 indexed citations
14.
Chen, Peng, Ke Zheng, Wei Wang, et al.. (2018). β-Alanine mediated inhibition of PTHR1suppresses the proliferation, invasion and tumorigenesis in metastatic human osteosarcoma U2OS cells. International Journal of Biological Macromolecules. 111. 1255–1263. 11 indexed citations
15.
Pei, Yi, Ke Zheng, Guanning Shang, et al.. (2018). Therapeutic Effect of Strontium Ranelate on Bone in Chemotherapy-Induced Osteopenic Rats via Increased Bone Volume and Reduced Bone Loss. Biological Trace Element Research. 187(2). 472–481. 3 indexed citations
16.
Wang, Wei, et al.. (2017). SPOCK1 promotes the growth of Osteosarcoma cells through mTOR-S6K signaling pathway. Biomedicine & Pharmacotherapy. 95. 564–570. 10 indexed citations
17.
Wang, Yuming, Wei Wang, & Enduo Qiu. (2017). Osteosarcoma cells induce differentiation of mesenchymal stem cells into cancer associated fibroblasts through Notch and Akt signaling pathway.. PubMed. 10(8). 8479–8486. 25 indexed citations
18.
19.
Qiu, Enduo, et al.. (2015). Surgical Indications of Exploring Optic Canal and Visual Prognostic Factors in Neurosurgical Treatment of Tuberculum Sellae Meningiomas. Chinese Medical Journal. 128(17). 2307–2311. 7 indexed citations
20.
Wang, Jian, et al.. (2009). Transcranial approach for treatment for traumatic optic chiasm syndrome. Acta Neurochirurgica. 151(12). 1711–1716. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026